eMedevents
  • 154,522+ Medical Conferences
  • 285 Specialties
  • 11,293 Organizers
  • 156,433 Speakers
  • 159 Countries
  • 4,785 Cities
51,507+
CME Conference Registrations Sold
Home  >  Speakers  >  Angelica S. I. Loskog
Angelica S. I. Loskog

Angelica S. I. Loskog

    PhD
Chief Executive Officer, Professor | Uppsala, Uppsala Lan    Sweden
Immunotherapies
Immunotherapies, Cancer Biomarkers,...More
Spoken at 3 events

Biography :

Loskog is the CEO of Lokon Pharma AB commercializing cancer immunotherapy invented at her lab at Uppsala University in Sweden. She was adjunct as full Professor of Immunotherapy at Uppsala University. She work as an advisor to the Swedish venture capital company Nxt2b AB, which also owns Lokon Pharma AB. She is the member, or chairman, of the board of several companies within the Nxt2b corporation such as Lokon, Vivolux, RePos Pharma, Bioimics and Hansa Medical. She was scientific advisor to other companies within the corporation such as Olink Proteomics.

**********************
*** ** ** ** **
   
For speaker's contact information - Contact us

Specialties

Immunotherapies

Interested Topics

Immunotherapies, Cancer Biomarkers, Oncology, Clinical Immunology, Dendritic Cells, Gene Therapy, Cancer Research, Flow Cytometry

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English
Close

Send Message